Issels Integrative Immuno-Oncology February 1, 2018  

New Device Rapidly Detects Cancer in Tissue Biopsies

Dear Friend,

One of the biggest roadblocks to successful cancer treatment is the difficulty of differentiating between healthy and diseased tissue. Cancer immunotherapy helps to address this problem, and researchers have announced development of a new device that may also improve outcomes.

Removing Cancer While Sparing Healthy Tissue

Surgery is a primary tool in the diagnosis and treatment of cancer, but there's a risk that some of the cancerous tissue may be left behind. Surgeons sometimes use cryosection, in which a frozen tissue sample is evaluated by a pathologist, but the method is time-consuming and not always accurate.

A study published in Science Translational Medicine reveals how a team of researchers in Texas created the MasSpec Pen to detect cancer in human tissue. This device uses the dysfunctional metabolism of cancer cells to differentiate them from normal cells.

Identifying Cancerous Cells Within Seconds

Once a molecular fingerprint has been drawn, the cells are analyzed using software that has been "trained" by processing hundreds of healthy and cancerous human tissue samples. Within 10 seconds, the sample is flagged as "Normal" or "Cancer."

The research team tested 253 samples of both normal and cancerous tissue with an accuracy rate of more than 96 percent. When the device was tested on mice, it again proved accurate without causing damage to healthy tissue. Testing in human cancer surgeries is expected to begin in 2018.

Cancer Immunotherapy at Issels®: A Personalized Treatment Program

No two cases of cancer are identical. At Issels®, we create a cancer immunotherapy program based on your specific needs. Contact us for more information.

New Device Rapidly Detects Cancer in Tissue Biopsies

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »

New Liquid Biopsy Finds Cancer Markers Even Before Illness for Early Action

A global health and research company has developed a liquid biopsy test which can detect cancerous mutant DNA in completely healthy people. The test utilizes gene sequencing to compare genetic markers within the person’s blood sample. Those markers are then contrasted with genetic markers found in common cancers such as ovarian, breast, lung, and colon cancers. If there are genetic markers that match, then the test has found evidence that the patient is at risk of contracting cancer in the future.

Get the Full Story!

Promising New Protocols for Breast Cancer Detection and Treatment

Past case records show that breast cancer has a history dating back to the days of ancient Egypt. Flash forward to the 21st century, where five innovative protocols are showing promise in more effective detection and treatment of breast cancer.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:

Google +

Contact Info:

Phone: 888-447-7357


Treatments | Testimonials | Contact Us